SYMPATH

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA (AFF009)

Topic / Pathology

  • Multiple System Atrophy (MSA)

Objectives

To have more informations, click on the link below:

https://clinicaltrials.gov/ct2/show/NCT02270489?term=affiris&cond=MSA+-…

Sponsor

Affiris

Scientific publication(s)

  • Meissner WG et al. A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy. Mov Disord. 2020 Nov;35(11):1957-1965. 

    https://pubmed.ncbi.nlm.nih.gov/32882100/

Status

Published results

Participating centers

Share

Updated on 17 February 2023